208 related articles for article (PubMed ID: 6391068)
21. GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats.
Nagatani M; Yamakawa S; Saito T; Ando R; Hoshiya T; Tamura K; Uchida K
Toxicol Pathol; 2013; 41(4):653-61. PubMed ID: 23076037
[TBL] [Abstract][Full Text] [Related]
22. Astrocytic characteristics of oligodendroglioma. Fine structural and immunohistochemical studies of two cases.
Kamitani H; Masuzawa H; Sato J; Kanazawa I
J Neurol Sci; 1987 May; 78(3):349-55. PubMed ID: 3585407
[TBL] [Abstract][Full Text] [Related]
23. Production of glial fibrillary acidic protein (GFAP) by neoplastic cells: adaptation to the microenvironment.
Herpers MJ; Budka H; McCormick D
Acta Neuropathol; 1984; 64(4):333-8. PubMed ID: 6391069
[TBL] [Abstract][Full Text] [Related]
24. Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system.
Tascos NA; Parr J; Gonatas NK
Hum Pathol; 1982 May; 13(5):454-8. PubMed ID: 6281168
[TBL] [Abstract][Full Text] [Related]
25. Uniform lineage of oligodendrogliomas.
de la Monte SM
Am J Pathol; 1989 Sep; 135(3):529-40. PubMed ID: 2675625
[TBL] [Abstract][Full Text] [Related]
26. Oligodendrogliomas: a clinical, histological, immunocytochemical and lectin-binding study.
Cruz-Sanchez FF; Rossi ML; Buller JR; Carboni P; Fineron PW; Coakham HB
Histopathology; 1991 Oct; 19(4):361-7. PubMed ID: 1937415
[TBL] [Abstract][Full Text] [Related]
27. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
Chen Y; Zhang YX
Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
[TBL] [Abstract][Full Text] [Related]
28. Oligodendroglial tumors. An immunohistochemical and electron microscopic study.
Sarkar C; Roy S; Tandon PN
Cancer; 1988 May; 61(9):1862-6. PubMed ID: 3355979
[TBL] [Abstract][Full Text] [Related]
29. CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tissue.
Hagel C; Stavrou DK
Neuropathol Appl Neurobiol; 1999 Aug; 25(4):313-8. PubMed ID: 10476048
[TBL] [Abstract][Full Text] [Related]
30. Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors.
Azzarelli B; Miravalle L; Vidal R
J Neuropathol Exp Neurol; 2004 Feb; 63(2):170-9. PubMed ID: 14989603
[TBL] [Abstract][Full Text] [Related]
31. Expression of granulocyte colony-stimulating factor in recurrent glial tumors is inversely correlated with tumor progression.
Stan AC; Walter GF; Welte K; Schneider B; Bona CA; Pietsch T
J Neuroimmunol; 1999 Feb; 94(1-2):66-73. PubMed ID: 10376937
[TBL] [Abstract][Full Text] [Related]
32. TPPP/p25 in brain tumours: expression in non-neoplastic oligodendrocytes but not in oligodendroglioma cells.
Preusser M; Lehotzky A; Budka H; Ovádi J; Kovács GG
Acta Neuropathol; 2007 Feb; 113(2):213-5. PubMed ID: 17136548
[No Abstract] [Full Text] [Related]
33. Glial fibrillary acidic protein (GFAP) in rat brain tumors transplacentally induced by ethylnitrosourea (ENU).
Mauro A; Giordana MT; Migheli A; Schiffer D
J Neurol Sci; 1983; 61(3):349-55. PubMed ID: 6361219
[TBL] [Abstract][Full Text] [Related]
34. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
[TBL] [Abstract][Full Text] [Related]
35. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
36. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
[TBL] [Abstract][Full Text] [Related]
37. Morphology of early stages of ENU-induced brain tumors in rats.
Mennel HD; Simon H
Exp Pathol; 1985; 28(4):207-14. PubMed ID: 3913606
[TBL] [Abstract][Full Text] [Related]
38. Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.
Rousseau A; Nutt CL; Betensky RA; Iafrate AJ; Han M; Ligon KL; Rowitch DH; Louis DN
J Neuropathol Exp Neurol; 2006 Dec; 65(12):1149-56. PubMed ID: 17146289
[TBL] [Abstract][Full Text] [Related]
39. Oligodendroglioma with signet-ring cell morphology: a case report with an immunohistochemical and ultrastructural study.
Mikami Y; Shirabe T; Hata S; Watanabe A
Pathol Int; 1998 Feb; 48(2):144-50. PubMed ID: 9589479
[TBL] [Abstract][Full Text] [Related]
40. GFAP in brain tumor diagnosis: possibilities and limitations.
Gullotta F; Schindler F; Schmutzler R; Weeks-Seifert A
Pathol Res Pract; 1985 Jul; 180(1):54-60. PubMed ID: 4034433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
